News
Gilead's Plan? Cash In on CAR-T
Investors eagerly awaiting news of how Gilead Sciences' (NASDAQ: GILD) plans to spend its growing mountain of cash found out on Monday that the company's plans to become a leader in cancer....
Gilead Sciences to Buy Kite Pharma for $11.9 Billion: Is It Enough to Move the Needle?
Gilead Sciences (NASDAQ: GILD), prompted by its falling sales of its hepatitis C drugs over the past year, has finally pulled the trigger on a much-anticipated buyout: On Monday, it offered to....
3 Reasons to Applaud Gilead Sciences' Acquisition of Kite Pharma
Finally.Gilead Sciences (NASDAQ: GILD) announced on Monday that it was acquiring Kite Pharma (NASDAQ: KITE) for $11.9 billion. Investors had long waited for the big biotech to make a deal. One....
If You Love Intuitive Surgical, You Should Check Out This Small-Cap Growth Stock
Few companies have done more to change healthcare over the past 20 years than Intuitive Surgical (NASDAQ: ISRG). The company singlehandily brought robotic surgery to the masses and in the process....
In Your 60s? 3 Stocks You Might Want to Buy
For many Americans, reaching their 60s is often the point where they transition out of the labor force and into retirement. It means putting that alarm clock to bed for good and putting your feet....
Can Buying Exelixis Stock Still Make You Rich?
What were you doing on Friday, Jan. 2, 2015? It's OK if you don't remember. I certainly can't.But there were some investors who did something on that date who probably recall it with a smile.....
Why I Love AbbVie Inc.
"Where your treasure is, there will your heart be also."Those profound words were spoken nearly 2,000 years ago. They were true then, and they're still true today. But even when your treasure is....
The Scariest Obamacare Statistic Yet
Though it seemed like a long shot just a few months ago, it looks as if in a little over two more months, Americans will once again be headed to their laptops and desktop computers to pore through....
Why You Can Back Up the Truck and Load Up on This Biotech Stock
Mae West once said, "Too much of a good thing can be wonderful." The late actress wasn't referring to investing, but her sentiment is still applicable. It makes sense to buy more shares of stocks....
These 3 Stocks Are Priced for Perfection. Can They Deliver?
Even great companies can turn into poor investments if you buy them at the wrong time. That's why it is important to take a hard look at a company's valuation before pulling the trigger.Shares of....
Here Are the Big Pharma Stocks to Own Based on R&D Spending
Just because a big pharma company is successful today doesn't mean it will be successful in a few years. Even the biggest blockbuster drugs eventually lose patent exclusivity or face new and....
3 Biotech Stocks That Could Soar in September
Winter seems to always be coming in Game of Thrones, but here in the real world, autumn is on the way. While the leaves will start falling in September, some biotech stocks could be set to....
Is the System Rigged Against Biosimilars?
If you think prescription drug costs are high now, imagine what costs would be without generic drugs. Roughly 25% of total prescription drug sales in 2016 were generics. But it's a different story....
3 States Where Obamacare Premiums May Rise More Than 50% in 2018
Despite President Trump having been in office for more than seven months now and Republicans retaining control of both houses of Congress, the Affordable Care Act, which is best known as....
Better Buy: Welltower Inc. vs. Universal Health Services, Inc.
America is getting older, and the demographic shift is driving up demand for healthcare facilities and services. This long-term trend should supply the nursing homes in Welltower Inc.'s (NYSE:....
Veeva Systems Inc Has Another Strong Quarter, but Slower Growth Could Be on the Horizon
This earnings season, Veeva Systems (NYSE: VEEV) once again demonstrated why it has become a mainstay in the pharmaceutical industry. The company, which provides a cloud platform for companies to....
3 Reasons Exact Sciences Is a Better Growth Stock Than Illumina
Illumina (NASDAQ: ILMN) has been -- and still is -- a leader in one of the most important scientific advances in human history. The company's technology helped usher in widespread use of gene....
Veeva Systems Inc. Is Tanking Today -- but Why?
Despite the company's good-looking earnings and a bullish guidance, shares of Veeva Systems (NYSE: VEEV), a provider of cloud-based business software to the life sciences industry, fell by 12% as....
70 or Older? 3 Stocks You Should Consider Buying
Investment priorities naturally evolve as we age. For investors in their 70s, stability and income should be prioritized over growth and capital appreciation potential. That's why companies like....
4 of the Highest-Growth Stocks in Biotech Today
Investing in the biotech industry can be a risky business. In most instances, the deck is stacked against a company succeeding. The vast majority of preclinical studies will fail to reach human....
Why Stryker, Ultragenyx Pharmaceutical, and La-Z-Boy Slumped Today
Major benchmarks trended downward Wednesday, taking a break from the rally that had boosted stocks in the previous session. Investors seemed uncertain about President Donald Trump's plans to....
Here's the Simple Reason Why Multiple Sclerosis Drugs Cost So Much
Two members of the U.S. House of Representatives Committee on Oversight and Government Reform want to know why the prices of multiple sclerosis (MS) drugs are so high. Rep. Elijah Cummings (D-Md.)....
Why Intra-Cellular Therapies Is Skyrocketing Today
Intra-Cellular Therapies (NASDAQ: ITCI), a clinical-stage biopharma focused on diseases of the central nervous system, rose more than 26% as of 11:35 a.m. EDT Wednesday. The big jump came in....
How Johnson & Johnson Makes Most of Its Money
As you might expect, Johnson & Johnson (NYSE: JNJ) makes a lot of money. Last year, the healthcare giant generated revenue totaling nearly $72 billion. Over the past decade, J&J raked in....
3 Reasons AbbVie Is a Better Dividend Stock Than Gilead Sciences
Gilead Sciences (NASDAQ: GILD) claims one of the top-selling drugs in the world with Harvoni. But AbbVie (NYSE: ABBV) markets the best-selling drug in the world -- Humira. Gilead Sciences is one....